Small Stocks, Big Money cover art

All Episodes

Small Stocks, Big Money — 139 episodes

#
Title
1

First Phosphate (FRSPF) CEO on Agnico's $94M Bet Leaves Only 2 Independents Standing

2

Anixa Biosciences (ANIX): CEO on Breast Cancer Vaccine, Phase 2 Catalyst & Ovarian Cancer CAR-T Data

3

CEO Brandon Robinson on Horizon Aircraft’s (HOVR) Commercial eVTOL Advantages

4

First Phosphate (FRSPF) CEO on $16.7M Non-Dilutive Funding, LFP Batteries, and Why FRSPF Stands Out

5

RedChip Highlights Enlivex Therapeutics Ltd. (NASDAQ: ENLV) & Off The Hook Inc. (NYSE American: OTH)

6

SCAP Portfolio Manager Jay Hatfield’s Market Playbook: Fed Cuts, Core PCE, and Small Caps

7

Enlivex (Nasdaq: ENLV) - FY25 Financial Results Webcast Replay

8

Enlivex (ENLV) CEO: Two Pillars of Growth, Allocetra Knee OA Catalyst + RAIN Treasury Optionality

9

Off The Hook (NYSE American: OTH) CEO Interview: $145M Revenue Path, AI Boat Platform, Apex Upside

10

Comprehensive Healthcare Systems (CMHSF | CHS): CEO Interview on Healthcare SaaS and Pipeline Growth

11

The Metals Company (TMC) CFO Craig Shesky: The NOAA Path, $23.6B NPV, and US Supply Security

12

BioVie (Nasdaq: BIVI) CEO Cuong Do on Near Term Catalysts in Parkinson’s, Long COVID, and Ascites

13

First Phosphate CEO John Passalacqua: Building a North American LFP Battery Supply Chain (FRSPF)

14

Nexalin Technology (NXL) CEO Mark White: FDA Trials, At-Home Neurostimulation, and 2026 Milestones

15

OBOOK Holdings (OWLS) CEO Darren Wang on Regulated Stablecoin Payments, OwlPay Growth and 2026 Goals

16

NioCorp (NB) CEO Mark Smith on 2025 Milestones, Elk Creek Portal Buildout, and U.S. EXIM Financing

17

ASP Isotopes (Nasdaq: ASPI) Investor Webinar - January 14, 2026

18

Avalon Advanced Materials CEO Interview | $4B Lithium Opportunity + Rare Earth Supply Chain Upside

19

Alliance Entertainment (NASDAQ: AENT) Chairman on Earnings Growth and Exclusive IP Strategy

20

Processa Pharmaceuticals (PCSA) Interview: Phase 2 Breast Cancer Data, Pipeline Strategy & FDA Path

21

New Era (Nasdaq: NUAI) CEO Discusses Power, AI Data Centers, and the Next Phase of Growth

22

NioCorp CEO Mark Smith on U.S. Critical Minerals, Scandium Demand, and Project Financing Progress

23

Nova Minerals CEO: $43.4M U.S. Funding Secured, Antimony Production by 2026 and 5.2Moz Gold Resource

24

BullFrog AI CEO Vin Singh: Using AI to Transform Drug Discovery and Cut Development Costs

25

Jackpot Digital CEO Jake Kalpakian on Disrupting the Casino Industry with Dealerless Poker Tech

26

Connect Biopharma CEO Barry Quart: Targeting a $5B+ Market with a Next-Gen Asthma & COPD Therapy

27

FatPipe Networks: CEO Dr. Ragula Bhaskar on Scaling Profitable Growth in SD-WAN and Cybersecurity

28

60 Degrees Pharmaceuticals: CEO Geoff Dow on Breakthrough Babesiosis Therapy & FDA Path Ahead

29

Inside Bimergen Energy: $250M Equity Backing & 2GW BESS Pipeline with CFO Bob Brilon

30

Inside Nexalin: Drug-Free Neuro Tech, Clinical Milestones, and What’s Next!

31

Lantern Pharma CEO Panna Sharma Discusses Progress in AI-Driven Cancer Drug Development

32

Foremost Clean Energy CEO on Nuclear's Resurgence & 330K Acre Uranium Portfolio

33

PhoenixEV CEO John Walsh Interview: 2025 Goals, $200M Backlog and Transit Growth

34

Inside 60 Degrees Pharmaceuticals: CEO Geoffrey Dow on Revenue Growth & Pipeline Potential

35

Aptevo Therapeutics: Inside a Top-Tier Oncology Pipeline with COO Jeff Lamothe

36

Investor Insights: Calidi CEO Eric Poma Discusses Breakthroughs in Oncolytic Virotherapy

37

Precision Oncology at Scale: Lantern Pharma’s Strategic Vision with CEO Panna Sharma

38

Inside Atossa Therapeutics: CEO Dr. Steven Quay Talks Pipeline, Progress, and Investor Outlook

39

Inside Processa Pharma: CEO George Ng on Disrupting Oncology Drug Development

40

Greenwich LifeSciences' CEO on Advancing HER2+ Immunotherapy | Phase III Insights & Strategy

41

How Fathom Holdings Is Disrupting Real Estate with Tech & Flat-Fee Innovation | CEO Marco Fregenal

42

ASP Isotopes CEO Paul Mann on Transforming Global Isotope Supply for Medicine, Clean Energy, & More!

43

Enlivex CEO on Revolutionizing Osteoarthritis Therapy with Allocetra™ | Investor Deep Dive

44

Inside 60 Degrees Pharma: CEO Geoffrey Dow on Fighting Infectious Diseases & Driving Growth

45

Uranium & Lithium Boom: Foremost Clean Energy CEO on the Future of North America's Supply

46

FatPipe (Nasdaq: FATN) CEO Talks Profitability, Patented Tech & Global Growth Strategy

47

BioVie CEO Cuong Do on Alzheimer’s Breakthroughs, Liver Disease Pipeline & What’s Ahead

48

Liberty Star Minerals: Leadership Breaks Down High-Grade Gold & Copper Potential in Arizona

49

Inside Atossa Therapeutics (Nasdaq: ATOS): CEO Dr. Steven Quay on Advancing Breast Cancer Treatment

50

Inside ConnectM: How AI Is Powering the $2 Trillion Electrification Boom

51

bioAffinity (Nasdaq: BIAF) CEO Maria Zannes Talks CyPath® Lung, Growth & AI Innovation

52

Interview with Connect Biopharma CEO Barry Quart | Transforming Acute Asthma & COPD Care

53

BullFrog AI CEO Vin Singh on Revolutionizing Drug Development with AI-Powered Insights

54

LiveOne (Nasdaq: LVO) CEO Robert Ellin on Disrupting Music, Media & Monetization

55

Inside Nexalin: CEO Mark White on TBI Solutions & Expanding Market Potential

56

Inside Knightscope (Nasdaq: KSCP): CEO William Santana Li on AI, Robotics & Crime Prevention

57

Jupiter Neurosciences CEO Christer Rosén on Advancing Neuroinflammation Treatments & Beyond

58

Alliance Entertainment: Inside The Billion-Dollar Giant Powering Media Distribution Globally

59

Inside Calidi Biotherapeutics: CFO Andrew Jackson Breaks Down the Future of Oncolytic Virotherapy

60

60 Degrees Pharmaceuticals (Nasdaq: SXTP) CEO Geoffrey Dow on Expanding Malaria Prevention & Beyond

61

Elevating Fan-Owned Live Entertainment: VENU Founder & CEO J.W. Roth Shares His Disruptive Approach

62

ASP Isotopes CEO Paul Mann on Breakthrough Isotope Tech, Quantum Computing & 2025 Growth Plans

63

Inside Enlivex: Oren Hershkovitz on Tackling Sepsis, Osteoarthritis, and Beyond with Allocetra™

64

Inside Gorilla Technology: CEO Jay Chandan & Interim CFO Bruce Bower on Smart Cities & Big Data

65

Inside OKYO Pharma’s (NASDAQ: OKYO) Phase 2 Trials with CEO Dr. Gary Jacob

66

Inside VSee Health’s Telehealth Revolution: Exclusive Interview with Co-CEO Dr. Imo Aisiku

67

Inside Can-Fite BioPharma’s (NASDAQ: CANF) Clinical Pipeline with CEO Motti Farbstein

68

How MUSQ ETF is Reshaping Music Investments: CEO David Shulhof Explains

69

The Future of Oncology: Calidi’s Stem Cell-Based Platforms for Fighting Cancer

70

How Alliance Entertainment (Nasdaq AENT) is Optimizing Operations for Continued Margin Improvement

71

The Gold Rush of 2024: Christopher Gerteisen’s Vision for Nova Minerals and Beyond

72

Interview with Founder of MUSQ Global Music Industry ETF

73

CEO Interview: ASP Isotopes is Commercializing New Isotope Enrichment Technology

74

CEO Interview: Discover How OKYO Pharma is Targeting the Multi-Billion-Dollar Dry Eye Disease Market

75

Learn Why Soligenix has Received $60M+ in Non-Dilutive Funding From the US Government: CEO Interview

76

Pioneering New Osteosarcoma and Breast Cancer Treatments: Exclusive Interview with OS Therapies' CEO

77

CEO INTERVIEW: American Resources Corporation's Unique Ability to Refine Critical Elements

78

GreenPower Leverages Government Mandates and Funding to Boost Zero-Emission School Bus Line Growth

79

Discover Nexalin's Neurostimulation Device Targeting Mental Health Disorders

80

Biotricity CEO, Waqaas Al-Siddiq, on New Heart Health Innovations & the Future of Cardiac Care

81

Hope for Lung Cancer Patients: Cypath Lung Test's Impact

82

Alta Global Group: Converting MMA fans into Participants. An Interview with CEO Nick Langton

83

Exploring Can-Fite BioPharma's Groundbreaking Drugs: Piclidenoson and Namodenoson

84

Unlocking Hope: The BioVie Journey in Neurodegeneration and Liver Disease

85

AI Solutions in the Online CBD Industry: A 1606 Corp. Perspective

86

Spectaire Holdings (Nasdaq: SPEC) Launches AireCore System for Emissions Management!

87

Genetic Technologies: Innovating Healthcare with Genomics-based Cancer Predictions

88

Unlocking Growth: Exploring LOBO EV's Path to Market Leadership in E-Bikes and EVs

89

Enlivex's (NASDAQ:ENLV) Allocetra™: Breakthrough Macrophage Reprogramming Therapy

90

Biotricity (NASDAQ: BTCY) Transforming Cardiac Care: Innovative Remote Monitoring Solutions

91

Unlocking Growth: Lytus Technologies - Your Next Nasdaq Investment Opportunity in Digital & Healthcare Innovation!

92

Biotricity (NASDAQ: BTCY) Revolutionizing Cardiac Care: Meet biotricity - Leading Remote Patient Monitoring Technology

93

Xcel Brands (NASDAQ:XELB): Leading the Social Commerce Revolution

94

1606 Corp. (OTC: CBDW): Revolutionizing CBD Customer Service with AI Innovation

95

Mobilicom (NASDAQ: MOB) Israel Ministry of Defense Purchases Mobilicom's Game-Changing Technology!

96

Meet Shalabh Gupta, CEO of Unicycive Therapeutics (NASDAQ: UNCY)

97

The INNO (NASDAQ: INHD) Edge: Transforming Construction with Cold-Formed Steel Technology

98

INNO Holdings Inc. (NASDAQ: INHD) - Redefining Construction with Steel Tech

99

Genetic Technologies Limited (NASDAQ: GENE): Pioneering Genomics for Health and Wellness

100

bioAffinity Technologies: Exploring the Future of Cancer Care

101

Meet Maria Zannes: CEO of BioAffinity Technologies (NASDAQ: BIAF)

102

Innovation in Flight: Mobilicom's End-to-End Solutions for Drone Cybersecurity

103

How Royalty Management Transforms Undervalued Assets

104

Meet Kirk Taylor: CFO of Royalty Management Holding Corporation (NASDAQ: RMCO)

105

Meet Paul Mann: CEO & Chairman of ASP Isotopes

106

Meet Denton Peng: CEO & Chairman of SPI

107

Meet Simon Morriss: CEO of Genetic Technologies (NASDAQ: GENE)

108

Meet Jonathan Guarino: CFO of Soligenix (NASDAQ: SNGX)

109

Meet Dr. Chris Schaber: CEO & President of Soligenix (NASDAQ: SNGX)

110

Meet Vu Truong, Founder and CEO of Aridis Pharmaceuticals (OTC: ARDS)

111

Everything Blockchain: Blending Database Security & Blockchain Technologies

112

Sharps Technology: Targeting Niche, Multi-Billion-Dollar Markets

113

Continental Lithium: Addressing the Rapidly Increasing Global Demand for Lithium

114

Soligenix: Late-Stage Biopharma Addressing a $2 Billion Opportunity

115

Graphex Group: Top-10 Global Producer of Graphite Anodes

116

Meet Shahar Hania, CEO of Rail Vision (NASDAQ:RVSN)

117

Splash Beverage: Ground-Floor Opportunity with High-Growth Beverage Brands

118

Soligenix: A Late-Stage Biopharma Pioneer Tackling Rare Diseases with Unmet Needs

119

ASP Isotopes: Advanced Materials Company Targeting Isotope Production

120

American Resources Corporation (NASDAQ: AREC): Focusing On Critical and Rare Earth Minerals for the Electrification Market

121

Meet Curt Marvis, The Man Behind QYOU Media. (OTCQB: QYOUF)

122

Aridis Pharma Founder & CEO Discusses Upcoming Milestones for its Late-Stage Pipeline

123

Interview with Sixty Degrees Pharma (Nasdaq: SXTP) CEO Geoff Dow

124

BioVie (NASDAQ: BIVI): Poised for Significant Catalysts in 2023

125

Meet Vin Singh, Founder & CEO of Bullfrog AI (NASDAQ:BFRG)

126

The Mark Jensen Story – From Wall Street Banker to Indiana Battery Recycler - American Resources Corporation (NASDAQ:AREC)

127

Rail Vision (NASDAQ: RVSN): Potentially Preventing Catastrophe’s Before They Occur

128

American Resources Corporation (NASDAQ: AREC): How this Company Turns Trash to Treasure

129

SPI Energy Group (NASDAQ: SPI): Unlocking Shareholder Value Under the Sun

130

Biovie (NASDAQ: BIVI): Innovating Potential Alzheimer’s and Parkinson’s Treatment

131

How Zomedica (NYSE American: ZOM) Is Changing the Veterinary Industry with Its Cutting-Edge Diagnostics and Therapeutics

132

End of the Exponential Equity Growth Era? Where to Invest Next

133

Continental Lithium: Addressing the Rapidly Increasing Global Demand for Lithium

134

Reviva Pharma (NASDAQ: RVPH) Charting Success: Reviva Pharma's Journey from phase 3 to Potential NDA filing

135

Unlocking Precision Medicine: BullFrog AI's (Nasdaq: BFRG) Trailblazing Use of AI to Predict Therapeutic Success and Transform Drug Development

136

QYOU Media (OTCQB: QYOUF) Media Mavericks: The Investment Potential of QYOU Media; India's Exponentially Growing Content Powerhouse

137

Sharps Technology, Inc. (NASDAQ: STSS): Sustainable Solutions, Profitable Investments: Inside the No Waste Syringe Revolution

138

Graphex Group Ltd. (NYSE American: GRFX) Unearthed: Unveiling the Hidden Powerhouse – The Podcast Exploring Graphex Groups Dominance in the Graphite Market

139

Lantern Pharma (NASDAQ: LTRN): Investing in Tomorrow's Cures: Unveiling the Power of AI Drug Development Platforms